Pharmaron’s Global DMPK Solutions brochure highlights its end-to-end capabilities in drug metabolism and pharmacokinetics (DMPK), supporting both small and large molecule programs from early discovery through to regulatory submission.
Whether you're optimizing lead compounds, conducting IND-enabling studies, or preparing for NDA filings, Pharmaron’s global team delivers high-quality, decision-ready data to help you move faster and with greater confidence.
What’s inside the eBook?
- Comprehensive DMPK services: In vitro ADME, in vivo PK/PD, metabolite ID, species selection, and regulatory bioanalysis.
- Advanced capabilities: Metabolomics, AMS, mass spectrometry imaging, microdialysis, and BBB penetration studies.
- Support from discovery to development: High-throughput screening, scalable in vitro ADME, predictive modeling, and workflows designed to reduce attrition.
- Regulatory expertise: IND/NDA-enabling studies, MIST, DDI risk assessments, and submission-ready reports aligned with FDA, EMA, and PMDA guidelines.
- Integrated bioanalysis: GLP/GCP-compliant quantification across all modalities, with embedded teams for faster, seamless data delivery.
- Modeling & simulation: PBPK, PK/PD, and population PK analysis to inform study design, dose selection, and regulatory planning.
- Strategic DMPK planning: DMPK planning aligned with your goals to minimize risk and accelerate clinic entry.
Complete the form to access the full eBook and learn how Pharmaron’s DMPK solutions can help streamline your development strategy.
About Pharmaron
Pharmaron is a premier R&D service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and CGT products. With over 17,000 employees, and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan and China.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.